Antidepressants and the placebo response

Human Psychopharmacology

Volumn 20, Issue 5, 2005, Pages 305-307

  Berk, Michael ^a   Dodd, Seetal ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATROPINE; PLACEBO;

CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMORBIDITY; DATA ANALYSIS; DEPRESSION; DISEASE COURSE; DRUG EFFICACY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HAMILTON SCALE; HUMAN; MEDICAL EXPERT; MEDICAL RESEARCH; META ANALYSIS; PATHOPHYSIOLOGY; PATIENT ATTITUDE; PATIENT EDUCATION; PERSONALITY; PHYSICIAN ATTITUDE; PREDICTION; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOLOGIC ASSESSMENT; PUBLIC HEALTH SERVICE; RATING SCALE; REWARD; SAMPLE SIZE; SIDE EFFECT; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; DEPRESSION; HUMANS; PLACEBO EFFECT; RESEARCH DESIGN;

EID: 23244435878     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.697     Document Type: Editorial

References (15)

1. Enserink M. 1999. Can the placebo be the cure? Science 284: 238-240.
2. Gaudiano BA, Herbert JD. 2005. Methodological issues in clinical trials of antidepressant medications: perspectives from psychotherapy outcome research. Psychother Psychosom 74: 17-25. Gaudiano BA, Herbert JD. 2005. Methodological issues in clinical trials of antidepressant medications: perspectives from psychotherapy outcome research. Psychother Psychosom 74: 17-25.
3. Khan A, Brodhead AE, Kolts RL, Brown WA. 2005. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials. J Psychiatr Res 39: 145-150.
4. Khan A, Brown WA. 2001. The placebo enigma in antidepressant clinical trials. J Clin Psychopharmacol 21: 123-125. Khan A, Brown WA. 2001. The placebo enigma in antidepressant clinical trials. J Clin Psychopharmacol 21: 123-125.
5. Khan A, Khan SR, Walens G, Kolts R, Giller EL. 2003. Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: an analysis of the food and drug administration summary basis of approval reports. Neuropsychopharmacology 28: 552-557.
6. Khan A, Kolts RL, Thase ME, Krishnan KR, Brown W. 2004. Research design features and patient characteristics associated with the outcome of antidepressant clinical trials. Am J Psychiatry 161: 2045-2049.
7. Lakoff A. 2002 The mousetrap: managing the placebo effect in antidepressant trials. Mol Interv 2: 72-76.
8. Lee S, Walker JR, Jakul L, Sexton K. 2004. Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation. Depress Anxiety 19: 10-19.
9. Moerman DE, Jonas WB. 2002. Deconstructing the placebo effect and finding the meaning response. Ann Intern Med 136: 471-476.
10. Moncrieff J, Wessely S, Hardy R. 1998. Meta-analysis of trials comparing antidepressants with active placebos. Br J Psychiatry 172: 227-231; discussion 232-224.
11. Montgomery SA. 1999. The failure of placebo-controlled studies. ECNP Consensus Meeting, September 13, 1997, Vienna. European College of Neuropsychopharmacology. Eur Neuropsychopharmacol 9: 271-276.
12. Murray CJ, Lopez AD. 1997. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349: 1498-1504. 0 Murray CJ, Lopez AD. 1997. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349: 1498-1504.
13. Thase ME. 2002. Studying new antidepressants: if there were a light at the end of the tunnel, could we see it? J Clin Psychiatry 63(Suppl. 2): 24-28. Thase ME. 2002. Studying new antidepressants: if there were a light at the end of the tunnel, could we see it? J Clin Psychiatry 63(Suppl. 2): 24-28.
14. Walsh BT, Seidman SN, Sysko R, Gould M. 2002. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 287: 1840-1847.
15. Zimmerman M, Posternak MA, Chelminski I. 2002. Symptom severity and exclusion from antidepressant efficacy trials. J Clin Psychopharmacol 22: 610-614.